AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
APG.MC

Axon Partners Group, S.A. (APG.MC) fair value

Industrials · Consulting Services · BME · Spain
€17.00+0.00%
Market cap €89MNext earnings 2025-04-30Updated Oct 22, 2026
Our verdict
Trades 25% below our fair value
Price
€17.00
Model fair valueConfidence: good
€22.73
Model range
€14.26 to €31.67
Fair value €22.73
Price €17.00
3 models fit Axon Partners Group, S.A. and they disagree: 1 of 3 land within 15% of the average.
Two or more of our models back this value.
Large discount(i)Bronze56
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionAxon Partners Group, S.A. (APG.MC)
Fair value (3 models)
€22.73
ACCE price target
€18.90
Rating
Undervalued
Horizon
12 months
Fair value published on 22 Oct 2026, 12:04 CEST.
ACCE price target published on 23 Oct 2026, 01:53 CEST.
Rating published on 22 Oct 2026, 12:04 CEST.
Price used: €17.00 at the close on 21 Oct 2026, 17:30 CEST.
Models: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
25.2% below
+33.7% to fair value
ACCE score
73
out of 100
P/E
13.9x
forward 10.8x
1-year return
+21.4%
Dividend yield
0.00%

Axon Partners Group, S.A. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Axon Partners Group is a Madrid-listed consulting firm whose revenue comes from advisory mandates in M&A, corporate finance and operational restructuring, sold mainly to mid-market and private-equity clients. Its 66% gross margin and 39.5% operating margin are unusually high for a people-driven advisory business, which points to tight cost control and pricing power rather than a scale advantage. Revenue grew 12.0% and ROE is 21.9%, so the franchise is compounding capital without much leverage, though at an 89M EUR market cap the business is small enough that a single lost client or deal slowdown would move results sharply. At 13.9x trailing and 10.8x forward earnings, the stock is priced for a modest decline in earnings, not for the 12% growth it has delivered, so the gap between the multiple and the reported growth is the first thing to test. The company is not in any index, which limits passive demand and can leave a mispricing in place for longer, but it also means liquidity is thin. A deeper look should focus on deal-flow cyclicality, client concentration, and whether the margin profile holds through a slow M&A cycle.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where APG.MC's valuation models land
Price
€17.00
Model fair value
€22.73
Model range
€14.26 to €31.67
Fair value €22.73
Price €17.00
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
+3.0%
1 month
-3.4%
3 months
+0.0%
6 months
+9.7%
YTD
+13.3%
1 year
+21.4%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:53 CESTACCE price target€18.90first publication€17.00
22 Oct 2026, 12:04 CESTFair value€22.73first publication€17.00
22 Oct 2026, 12:04 CESTRatingUndervaluedfirst publication€17.00

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full APG.MC page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth60Value68Quality95Momentum70Total73
Valuation
Trailing P/E
13.9x
Forward P/E
10.8x
PEG
0.97
P/B
3.23x
EV / Revenue
3.1x
Book value/sh
€5.26
Enterprise value
€83M
Profitability
ROE
21.9%
FCF yield
1.69%
ROIC
17.6%
Health and risk
Debt / equity
0.08
Dividend yield
0.00%
Beta
-0.00

Price

+23.2% · 1Y

Ask anything about APG.MC

Answered from Axon Partners Group, S.A. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 50% of peers
low 0.0x13.9xhigh 143.5x
ROEbetter than 83% of peers
low -250%22%high 54%
Div yieldbetter than 83% of peers
low 0.0%0.0%high 11.0%

Peers

Prices Oct 21, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
APG.MC Axon Partners Group, S.A.€17.00€2325% below13.9x21.9%9573
RGP Resources Connection Inc. Common Stock$2.69----25.1%3930
AAA.PA Alan Allman Associates€1.70€456% below42.5x4.7%2532
LLYC.MC Llorente & Cuenca, S.A.€5.25--11.4x54.1%6753
DGNX Diginex Limited Ordinary Shares$1.40----250.4%4726
FORR Forrester Research Inc. Common Stock$12.48$134% below--30.3%4463
ACCL Acco Group Holdings Limited Class A Ordinary Shares$2.87--143.5x14.8%6347

Sector report card

Where APG.MC ranks against its sector peers on each metric.

Computing percentiles…